Source: Eur Respir J 2016; 48: 962
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Schermuly, Werner Seeger, Friedrich Grimminger, Andreas M. Zeiher, Stefanie Dimmeler, Helge Möllmann, Christian W. Hamm, Hossein Ardeschir Ghofrani and Holger M. Nef. Eur Respir J 2015; 46: 1390–1396.. “New potential diagnostic biomarkers for pulmonary hypertension.”. Eur Respir J 2016; 48: 962

Member's Comments

No comment yet.

Related content which might interest you: New potential diagnostic biomarkers for pulmonary hypertension Source: Eur Respir J 2015; 46: 1390-1396 Year: 2015 Screening for biomarkers in pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012 Identification of novel diagnostic biomarkers of chronic thromboembolic pulmonary hypertension using MALDI-TOF-MS Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 New aspects of pharmacological correction of pulmonary hypertension in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 236s Year: 2002 Novel biomarkers for risk stratification in pulmonary arterial hypertension Source: ERJ Open Res 2015; 1: 00008-2015 Year: 2015 Fibrocytes: potential new therapeutic targets for pulmonary hypertension? Source: Eur Respir J 2010; 36: 1232-1235 Year: 2010 New therapeutic targets in pulmonary arterial hypertension (PAH): moving from preclinical data to phase 2 studies Source: International Congress 2018 – New trends in the management of pulmonary hypertension Year: 2018 Towards prognostic biomarkers in pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 799-801 Year: 2012 Evaluation of recently validated non-invasive formula using basic lung functions as a new screening tool for pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Different definitions of pulmonary hypertension in interstitial lung disease: a prognostic evaluation. Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 The new definition of pulmonary hypertension Source: Eur Respir J 2009; 34: 790-791 Year: 2009 New radiological diagnostic criteria: impact on idiopathic pulmonary fibrosis diagnosis Source: Eur Respir J, 54 (5) 1900905; 10.1183/13993003.00905-2019 Year: 2019 Potential new biomarkers for idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 New horizons in pulmonary arterial hypertension therapies Source: Eur Respir Rev 2013; 22: 503-514 Year: 2013 Challenges in the diagnosis and treatment of pulmonary arterial hypertension Source: Eur Respir Rev 2012 21: 313-320 Year: 2012 A noninvasive algorithm to exclude pre-capillary pulmonary hypertension Source: Eur Respir J 2011; 37: 1096-1103 Year: 2011 The clinical role of routine non-invasive parameters in the diagnostic work-up of patients with risk for pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012 New horizons in pulmonary arterial hypertension management Source: Eur Respir Rev 2014; 23: 408-409 Year: 2014 Novel biomarkers in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010